← Eichor
Study identifier: NCT06884410 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Reproducibility of Multiparametric Renal Magnetic Resonance Imaging on 1.5T MRI Scanners

Condition: Multiparametric MRI  ·  Sponsor: Mario Negri Institute for Pharmacological Research

PhaseNA
Planned participants48
Who can joinAll sexes, 18 Years to 70 Years
Healthy volunteersYes

About this study

This is an interventional, multicenter, prospective study involving healthy volunteers, to primarily assess the reproducibility of multiparametric renal MRI on 1.5T scanners. The study is also aimed at assessing possible differences in renal MRI reproducibility on 1.5T MRI scanners by sex and age, and assessing possible differences in renal MRI reproducibility across field strengths (1.5T vs 3T) in the subgroup of subjects enrolled in both RESPECT clinical study and in the current subproject.

This description comes directly from the study's public registry record.

Talk to the study team

Matias Trillini, M.D.  ·  +390354535411  ·  matias.trillini@marionegri.it

Always discuss trial participation with your own doctor first.

Locations (4)

Aarhus University HospitalAarhus, DenmarkNot Yet Recruiting
University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg UniversityMannheim, GermanyNot Yet Recruiting
IRCCS Azienda Ospedaliero-Universitaria di BolognaBologna, BO, ItalyRecruiting
Clínica Universidad de NavarraPamplona, Navarre, SpainNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06884410